StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Filana Therapeutics's enterprise value was -$59.39M on Nov 11, 2026, against $50.92M a year earlier. Over the last 5 years it ranged from -$59.39M to $1.53B, with a median of $710.61M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$59.39M–
2025Dec 31, 2025-$10.43M–
2024Dec 31, 2024-$35.75M-104.4%
2023Dec 29, 2023$805.99M-20.1%
2022Dec 30, 2022$1.01B-33.1%
2021Dec 31, 2021$1.51B+902.3%
2020Dec 31, 2020$150.37M+109.6%
2019Dec 31, 2019$71.74M–
2018Dec 31, 2018-$5.81M-140.1%
2017Dec 29, 2017$14.47M+218.2%
2016Dec 30, 2016$4.55M-89.8%
2015Dec 31, 2015$44.48M-9.2%
2014Dec 31, 2014$49.00M-70.7%
2013Dec 31, 2013$167.52M+100.8%
2012Apr 30, 2012$83.44M-27.8%
2011Jul 29, 2011$115.60M–

More Filana Therapeutics figures

See a number that looks wrong?